Subscribe To
Neumora therapeutics to participate in upcoming conferences in november
WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical...
October 30, 2023, 7:00 am
Miromatrix medical stock soars after it agrees to be bought by united therapeutics
Miromatrix Medical Inc.'s stock MIRO, -2.80% jumped 230% in premarket trades on Monday after the company agreed to be acquired by United Therapeutics ...
October 30, 2023, 6:23 am
Opthea to present at eyecelerator forum at the 2023 american academy of ophthalmology (aao) conference
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical...
October 30, 2023, 5:30 am
Reneo pharmaceuticals: buy before upcoming pivotal data drop
Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavodelpar or REN001. Mavodelpar has shown promising ...
October 29, 2023, 8:00 pm
Alzheimer's medication: eisai reporting positive data on injectable drug
This segment originally aired on October 26, 2023. Eisai has (EISAY) reported positive results in clinical...
October 28, 2023, 9:00 am
Aledade celebrates the election of dr. jen brull as president of the american academy of family physicians
Aledade’s Vice President of clinical Engagement becomes the president-elect of the largest medical so...
October 27, 2023, 6:41 pm
Dbv technologies to report third quarter 2023 financial results and business update
Montrouge, France, October 27, 2023 DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update DBV Technologies (Euronext: DB...
October 27, 2023, 4:30 pm
Acumen pharmaceuticals presents late-breaker phase 1 updates exploring novel target engagement, dosing regimen and safety findings for acu193 in early alzheimer’s disease at the 16th annual clinical t
– Acumen presented data exploring target engagement modeling of ACU193, the first clinical-stage amyl...
October 27, 2023, 1:25 pm
Cognition therapeutics and collaborators at yale and actc announce oral late-breaking presentation on the start study in early alzheimer’s disease at ctad
NEW YORK, Oct. 27, 2023 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (NASDAQ: CGTX) announced that Christoper van Dyck, M.D., the director of the...
October 27, 2023, 11:30 am
Seelos therapeutics to present a poster on sls-005 in alzheimer's disease at neuroscience 2023
-SLS-005 induces autophagy to reduce mutant protein aggregates, and is currently being studied in Alzheimer's disease, Huntington's disease, Amyotroph...
October 27, 2023, 8:11 am
Why is nkgen biotech (nkgn) stock up 18% today?
NKGen Biotech (NASDAQ: NKGN )) stock is taking off on Friday with continued growth after announcing clinical<...
October 27, 2023, 7:50 am
Medicinova’s collaborator initiates clinical development of a gene therapy product for the treatment of phenylketonuria
LA JOLLA, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
October 27, 2023, 5:00 am
Eli lilly bowel disease drug approved in us
Eli Lilly and Co (NYSE:LLY) has announced that its Omvoh drug has been approved by the US Food and Drug Administration to treat types of inflammatory ...
October 27, 2023, 3:52 am
Monte rosa therapeutics announces $25 million registered direct offering, priced at- the-market under nasdaq rules
BOSTON, Oct. 26, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-sta...
October 26, 2023, 8:30 pm
Bio-rad laboratories, inc. (bio) q3 2023 earnings call transcript
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q3 2023 Results Conference Call October 26, 2023 5:00 PM ET Company Participants Edward Chung - Head, IR Norman...
October 26, 2023, 8:04 pm
Paxmedica’s research on low dose suramin for autism spectrum disorder accepted for publication
TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) — via IBN — PaxMedica, Inc. (Nasdaq: PXMD) a clinical...
October 26, 2023, 5:51 pm
Why is paxmedica (pxmd) stock up today?
PaxMedica (NASDAQ: PXMD ) stock is jumping significantly higher against the backdrop of another soft session on Wall Street. This morning, management ...
October 26, 2023, 2:42 pm
Aptose to report third quarter 2023 financial results and hold conference call on thursday, november 9, 2023
SAN DIEGO and TORONTO, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a c...
October 26, 2023, 7:11 am
Bsf enterprise flutters higher as lab-grown cornea subsidiary created
BSF Enterprise PLC (LSE:BSFA) shares fluttered 8% higher to 8.2% after the bio-tissues company formed a division to focus on lab-grown corneas. Kerato...
October 26, 2023, 4:03 am
Eisai presents new leqembi® (lecanemab-irmb) investigational subcutaneous formulation interim study results and clinical improvement data in earlier stages of early alzheimer’s disease from additional
Investigational Subcutaneous Formulation Clears 14% More Plaque Than IV, Pharmacokinetics (AUC) 11% Higher, And Similar ARIA Rates To IV 76% Of Patien...
October 25, 2023, 9:26 pm